Associative Visual Agnosia

Associative visual agnosia is a neurological disorder in which a person can perceive basic visual elements—such as shape, color, and contour—but cannot link that perceptual information to stored knowledge about objects. In other words, although the individual sees and can describe what an object looks like, they cannot identify its meaning or use. This condition arises from damage to the brain’s ventral stream (the “what” pathway), typically in the occipitotemporal regions. Importantly, vision for acuity or motion remains intact; the deficit lies in the semantic association between perception and object knowledge.

Associative Visual Agnosia is a rare disorder in which the eyes and early visual cortex accurately capture a scene, yet the brain fails to link that intact percept to stored meaning. People can copy or match an object almost perfectly, but they cannot name it or describe its use. Damage typically lies in the left occipito-temporal junction or the splenium of the corpus callosum, often after stroke, head injury, hypoxia, tumour, infection or degenerative disease. en.wikipedia.org

Think of sight as a two-step relay. Step one builds the picture (apperceptive stage). Step two tags that picture with meaning (associative stage). In AVA the first step works, the second misfires. The “what-is-it?” highway between the ventral visual stream and semantic memory is blocked. Patients complain of “blurry knowing” rather than blurry vision: they bump into familiar tools, misplace toothbrushes, misrecognise pets, yet can sketch them with stunning accuracy. Mood swings, frustration, and withdrawal are common because the world suddenly feels alien. No single cure exists; care revolves around neuro-rehabilitation, assistive technology, and treating the underlying brain injury my.clevelandclinic.orgtandfonline.com.

Associative visual agnosia often follows stroke, traumatic brain injury, or degenerative diseases such as Alzheimer’s. Patients may see a key’s ridges and overall shape yet fail to recognize it as “a key.” They might draw accurate copies of objects but still be unable to name them. Everyday tasks—like recognizing faces, reading words, or navigating familiar environments—can be profoundly disrupted. Nevertheless, because primary vision is preserved, individuals often remain unaware that their difficulty in recognition stems from a neurological impairment rather than from poor eyesight.

---

Types of Associative Visual Agnosia

1. General Object Agnosia
   In this form, the patient cannot recognize a wide variety of inanimate and animate objects, despite intact vision. They may describe an object’s shape and color accurately but cannot name or explain its function. This widespread failure highlights damage to core semantic networks that link visual input to conceptual memory.

2. Prosopagnosia (Face Agnosia)
   Prosopagnosia is a subtype focused on faces. Individuals can see facial features—eyes, nose, mouth—but cannot recognize familiar people by sight. They often rely on alternative cues such as voice, hairstyle, or clothing. Prosopagnosia results from lesions in the fusiform face area of the temporal lobe.

3. Pure Alexia (Word Form Dyslexia)
   Here, patients lose the ability to read printed words despite normal writing ability and preserved verbal language. They can copy text but cannot comprehend it. The disorder arises when the visual word form area in the left occipitotemporal cortex is compromised, disconnecting perceptual word recognition from language centers.

4. Topographical Agnosia
   Affected individuals cannot recognize or navigate familiar environments. They may view a map or landscape accurately but fail to interpret it as a known location. This form is linked to right parahippocampal and retrosplenial cortex damage, crucial for spatial memory and scene recognition.

5. Color Agnosia
   Patients see colors normally but cannot associate them with objects or name them. For instance, they might not know that bananas are typically yellow. Lesions in the left anterior fusiform gyrus disrupt the link between color perception and semantic knowledge.

6. Category-Specific Agnosia
   Some individuals lose recognition for only particular categories, such as living things (animals, plants) or nonliving things (tools, vehicles). This selective failure suggests that semantic memory is organized by category and that different neural circuits underlie knowledge of different object classes.

---

Causes of Associative Visual Agnosia

1. Ischemic Stroke
   A blockage in a brain artery reduces blood flow to occipitotemporal regions. Without oxygen, neurons in the ventral stream die, leading to agnosia.

2. Hemorrhagic Stroke
   Bleeding within the brain can compress and damage visual association areas. Depending on the bleed’s location, associative agnosia may arise suddenly.

3. Traumatic Brain Injury (TBI)
   Blunt force to the head—such as from a fall or collision—can shear neural connections in the visual pathways, disrupting associations between perception and memory.

4. Alzheimer’s Disease
   Progressive atrophy often affects the temporal lobe, where object recognition circuits reside. Early-stage Alzheimer’s can manifest as mild agnosia for important objects and faces.

5. Semantic Dementia
   A subtype of frontotemporal dementia, semantic dementia selectively erodes conceptual knowledge. Even with intact vision, patients cannot interpret what they see.

6. Temporal Lobe Epilepsy
   Seizure activity in the temporal lobe can injure cortical areas responsible for linking visual input to semantics, occasionally resulting in chronic agnosia.

7. Carbon Monoxide Poisoning
   CO displaces oxygen in the blood, causing hypoxic injury. The occipitotemporal cortex is especially vulnerable, and survivors may develop associative defects.

8. Encephalitis
   Inflammation of the brain—caused by viruses or autoimmune reactions—can damage visual association areas, resulting in agnosia among other deficits.

9. Brain Tumors
   Masses in the ventral stream region, such as gliomas or meningiomas, may compress or infiltrate key areas for object recognition.

10. Surgical Resection
    Removal of epileptic foci or tumors in the temporal lobe can inadvertently remove healthy tissue, leading to associative agnosia.

11. Multiple Sclerosis
    Demyelinating plaques in the brain’s white matter tracts can sever connections between visual and semantic centers, producing recognition deficits.

12. Progressive Supranuclear Palsy
    This degenerative disorder can involve occipital and temporal regions, resulting in visual and semantic processing impairments.

13. Wilson’s Disease
    Copper accumulation in the brain can damage the basal ganglia and adjacent regions, sometimes extending to occipitotemporal areas.

14. Creutzfeldt–Jakob Disease
    This prion disease rapidly destroys cortical neurons, including those needed for associating visual perception with meaning.

15. Huntington’s Disease
    Although primarily affecting movement, Huntington’s can also involve cortical degeneration in associative visual areas over time.

16. Toxic Encephalopathy
    Exposure to heavy metals like lead or mercury can injure cortical neurons, including those in the visual association cortex.

17. Hypoglycemic Brain Injury
    Severe low blood sugar can cause neuron death in sensitive regions, occasionally involving the occipitotemporal cortex.

18. Hypoxic–Ischemic Encephalopathy
    Cardiac arrest or respiratory failure may globally deprive the brain of oxygen; associative areas are among the first to suffer.

19. Neurosyphilis
    Untreated syphilis can invade the brain’s cortex, leading to general paresis that may include agnosic symptoms.

20. Herpes Simplex Encephalitis
    HSV infection often affects the temporal lobes. Survivors can exhibit persistent associative visual agnosia due to scarring.

---

Symptoms of Associative Visual Agnosia

1. Inability to Name Objects
   Despite seeing an object clearly, the patient cannot retrieve its name from memory.

2. Accurate Drawing with No Recognition
   Patients may reproduce an object’s shape on paper yet not realize what they have drawn.

3. Reliance on Nonvisual Cues
   Individuals use touch, smell, or sound to identify familiar items.

4. Difficulty Recognizing Faces
   A subset of patients cannot identify friends or family by sight, despite intact face perception.

5. Trouble Reading Familiar Words
   Pure alexia can manifest as inability to read printed text, even though writing and spelling remain intact.

6. Misuse of Objects
   Patients may hold a fork upside-down or use a comb incorrectly due to failure to associate function.

7. Impaired Color Naming
   In color agnosia, patients see color patches but cannot label them or recognize typical color–object associations.

8. Navigation Difficulties
   Topographical agnosia causes getting lost in previously familiar environments.

9. Semantic Errors
   A patient might call a watch a “clock” or a “bracelet,” reflecting confusion at the semantic level.

10. Slow Object Recognition
    The process of identifying items is unusually prolonged and effortful.

11. Frustration and Anxiety
    Inability to recognize everyday items often leads to emotional distress and social withdrawal.

12. Overreliance on Context
    Recognition may succeed only when objects appear in stereotyped scenes (e.g., a sink in a kitchen).

13. Confusion Between Similar Items
    Patients mix up objects from the same category, such as different tools.

14. Preserved Motion Perception
    Despite agnosia, patients can track moving objects normally, highlighting the specificity of their deficit.

15. Intact Visual Acuity
    Standard eye exams show normal or near-normal vision, distinguishing agnosia from ophthalmologic causes.

16. Difficulty with Abstract Symbols
    Besides words, symbols like logos or icons may not be recognized.

17. Delayed Recognition After Multiple Exposures
    Even repeated viewing may not help patients name an object.

18. Inconsistent Performance
    Recognition may fluctuate from trial to trial, depending on attention or fatigue.

19. Difficulty Matching Pictures to Real Objects
    Patients may match two pictures correctly but fail to link a picture with the real object.

20. Social Embarrassment
    Mistaking people or objects in public can lead to shame and avoidance of social situations.

---

Diagnostic Tests for Associative Visual Agnosia

Physical Examination

1. Standard Visual Acuity Test
   Uses a Snellen chart to confirm that poor recognition is not due to reduced clarity of vision.

2. Visual Field Assessment
   Perimetry maps the patient’s field of view to ensure that blind spots do not underlie recognition failures.

3. Color Vision Screening
   Ishihara plates or Farnsworth D-15 test detect color blindness, which must be ruled out before diagnosing color agnosia.

4. Ocular Motility Exam
   Assessment of eye movements ensures that oculomotor problems aren’t interfering with object scanning.

5. Pupil Response Test
   Checks pupillary constriction and dilation to rule out optic nerve or brainstem pathology.

6. Fundoscopic Examination
   Ophthalmoscopy inspects the retina and optic disc to exclude retinal or optic nerve lesions.

7. Peripheral Vision Check
   Confrontation testing helps detect gross field deficits that might mimic agnosia.

8. Contrast Sensitivity Test
   Evaluates the ability to distinguish between subtle shades of light and dark, often intact in agnosia.

Manual (Behavioral) Tests

1. Object Naming Task
   The patient is shown common objects (e.g., a key, a pen) and asked to name them.

2. Object Use Demonstration
   Patients are given an object and asked to demonstrate how to use it, revealing functional knowledge.

3. Drawing-to-Command
   The examiner instructs the patient to draw a bicycle or house, assessing internal visual representation.

4. Picture–Object Matching
   Matching pictures of objects to real items tests the link between depiction and reality.

5. Face Recognition Test
   Famous Faces or Cambridge Face Memory Test measures prosopagnosia severity.

6. Word Reading Aloud
   Patients read printed words to uncover pure alexia.

7. Color Naming Exercise
   The patient names or sorts colored patches to evaluate color agnosia.

8. Scene Recognition Task
   Photographs of familiar locations (e.g., a school hallway) are shown to assess topographical agnosia.

Lab and Pathological Tests

1. Complete Blood Count (CBC)
   Rules out systemic infection or anemia that might contribute to cognitive dysfunction.

2. Metabolic Panel
   Checks glucose, electrolytes, and liver/kidney function to detect metabolic encephalopathies.

3. Thyroid Function Tests
   Hypothyroidism can mimic cognitive decline, so TSH and free T4 levels are assessed.

4. Vitamin B12 and Folate Levels
   Deficiencies may cause neurological symptoms, so these are measured.

5. Autoimmune Panel
   Antibodies against neuronal antigens (e.g., anti–NMDA receptor) can indicate autoimmune encephalitis.

6. Infectious Disease Screen
   Tests for syphilis, HIV, and Lyme disease help identify treatable causes of cortical damage.

7. CSF Analysis
   Lumbar puncture examines cerebrospinal fluid for infection, inflammation, or prion disease.

8. Toxicology Screen
   Detection of heavy metals or toxins clarifies whether exposure underlies cortical injury.

Electrodiagnostic Tests

1. Electroencephalography (EEG)
   Records brain electrical activity to detect seizures or slow waves in affected regions.

2. Evoked Potential Testing
   Visual evoked potentials (VEPs) assess the integrity of the visual pathway from retina to cortex.

3. Somatosensory Evoked Potentials
   Rule out widespread cortical dysfunction by stimulating peripheral nerves.

4. Brainstem Auditory Evoked Response
   Ensures that brainstem conduction is intact, helping localize lesions to cortical areas.

5. Magnetoencephalography (MEG)
   Maps functional activity in the ventral stream during visual tasks.

6. Transcranial Magnetic Stimulation (TMS)
   Can transiently disrupt or activate cortical regions to confirm their role in object recognition.

7. Nerve Conduction Studies
   Exclude peripheral neuropathies that might confound sensory-based identification tasks.

8. Electrocorticography (ECoG)
   In surgical candidates, direct cortical recordings can precisely localize dysfunctional areas.

Imaging Tests

1. Magnetic Resonance Imaging (MRI)
   High-resolution structural imaging identifies lesions in the occipitotemporal cortex.

2. Functional MRI (fMRI)
   Detects brain activation patterns during object recognition tasks, highlighting underactive regions.

3. Diffusion Tensor Imaging (DTI)
   Visualizes white matter tracts in the ventral stream to detect disrupted connectivity.

4. Computed Tomography (CT) Scan
   Quick assessment for hemorrhage or mass lesions when MRI is contraindicated.

5. Positron Emission Tomography (PET)
   Measures glucose metabolism in associative areas, showing hypometabolism in agnosic regions.

6. Single-Photon Emission Computed Tomography (SPECT)
   Assesses regional cerebral blood flow to identify dysfunctional cortical areas.

7. Magnetic Resonance Spectroscopy (MRS)
   Analyzes biochemical changes in brain tissue, detecting neuronal loss or gliosis.

8. High-Resolution 3D Volumetry
   Quantifies atrophy in specific ventral stream structures, aiding diagnosis of degenerative cases.

Non-Pharmacological Treatments

A. Physiotherapy & Electrotherapy 

1. Visual Scanning Training – therapist teaches systematic left-to-right sweeps so the brain re-labels objects in context; boosts top-down semantic cues.

2. Contrast Sensitivity Drills – graded black-white patterns strengthen ventral cortical responsiveness, enhancing object edges.

3. Patterned Light Therapy – alternating high-frequency light bars drive Hebbian plasticity in residual association cortex.

4. Computerised Object-Recognition Games – adaptive difficulty re-exposes patients to shape-meaning pairs, encouraging rewiring flintrehab.com.

5. Prism Adaptation – small lens shifts force visuomotor recalibration, indirectly tightening vision-meaning coupling.

6. Repetitive TMS over left occipito-temporal gyrus—low-frequency pulses disinhibit nearby networks and promote semantic recovery pmc.ncbi.nlm.nih.gov.

7. Transcranial Direct-Current Stimulation (tDCS) – 2 mA anodal currents for 20 min prime plasticity pre-therapy.

8. Neuromuscular Re-education for eye-hand coordination reduces clumsiness in daily tasks.

9. Virtual-Reality Kitchen Simulation – safe environment to practise identifying household tools.

10. Mirror Therapy for Tool Use – watching intact movements in VR primes semantic affordances.

11. Colored Overlay Filters – stabilise figure–ground segregation, easing recognition.

12. Audio-Tactile Substitution Devices – convert edges into musical tones, gradually re-linking vision with meaning.

13. Stroboscopic Vision Glasses – brief occlusions force predictive coding and deeper semantic processing.

14. Visual Cue Card Libraries – therapist builds personalised flash-cards with labels to anchor memory.

15. Eye-Tracking Biofeedback – real-time gaze heatmap teaches more efficient fixations.

B. Exercise Therapies 
16. Tai Chi with Object Flow – slow, object-centred movements reinforce visuomotor binding.
17. Task-Oriented Reach-to-Grasp Practice – repetitive pantry-to-counter transfers embed semantic affordances.
18. Dual-Task Walking while naming visible landmarks trains divided attention.
19. Yoga Sun Salutation with Visual Focus – sustained gazes sharpen perceptual constancy.
20. Interactive Exergames (e.g., VR ping-pong) push rapid object identification under playful stress.

C. Mind-Body 
21. Mindfulness-Based Stress Reduction lowers anxiety that otherwise narrows attentional spotlight.
22. Cognitive-Behavioural Therapy addresses depression from functional loss.
23. Guided Imagery—patients visualise naming success to prime neural assemblies.
24. Music Therapy uses melody-driven semantic networks to piggy-back object meaning (e.g., sing “brush-brush-brush” when seeing toothbrush).
25. Biofeedback-assisted Relaxation curbs sympathetic over-arousal that degrades semantic retrieval.

D. Educational Self-Management 
26. Errorless Learning Modules – clinician prevents early mistakes, preserving confidence and consolidating correct labels.
27. Environment Labeling – big-print tags on drawers, appliances, and cupboards provide constant real-world rehearsal my.clevelandclinic.org.
28. Diary-Based Reflection – patients log objects missed or misused, identify patterns, and adjust strategies.
29. Family Training Workshops teach supportive cueing rather than “testing” the patient.
30. Smartphone Reminder Apps with object photos and voice-notes nudge correct usage at the right moment.

---

Evidence-Based Drugs (supportive/secondary)

(Always prescribed by a neurologist; typical adult doses given for context only.)

1. Donepezil 5–10 mg nightly – cholinesterase inhibitor; may improve semantic retrieval, especially when AVA coexists with posterior cortical atrophy; side-effects: nausea, vivid dreams.

2. Rivastigmine 9.5 mg/24 h patch – similar rationale; skin irritation possible.

3. Galantamine 8-24 mg/day – dual AChE inhibitor/nicotinic modulator; cautions in bradycardia.

4. Memantine 10 mg b.i.d. – NMDA antagonist; reduces glutamate excitotoxicity post-stroke; dizziness common.

5. Citicoline 500 mg b.i.d. – nucleotide precursor; supports neuronal membrane repair; rare insomnia.

6. Piracetam 1.2 g t.i.d. – nootropic improving micro-circulation; bland side-effect profile.

7. Levodopa/Carbidopa 100/25 mg t.i.d. – off-label for visual perceptual disorders in Lewy-body pathology; may cause dyskinesia.

8. Bromocriptine 2.5 mg b.i.d. – dopaminergic; reported to sharpen object naming in some case series; watch hypotension.

9. Sertraline 50 mg morning – treats reactive depression; helps engagement in rehab.

10. Methylphenidate 5-20 mg morning – augments attention networks; contraindicated in uncontrolled hypertension.

11. Modafinil 200 mg morning – promotes wakefulness; improves sustained attention for therapy sessions.

12. Omega-3 ethyl-esters 1 g t.i.d. – prescription-strength; anti-inflammatory neuro-protection; fishy burps possible.

13. Acetazolamide 250 mg b.i.d. – lowers intracranial pressure when AVA follows pseudotumor cerebri.

14. Topiramate 25-50 mg nocte – migraine prophylaxis if visual aura complicates recognition; risk of word-finding trouble.

15. Valproate 500-1000 mg daily – seizure control when occipital epilepsy co-exists; monitor liver enzymes.

16. Aspirin 81 mg daily – secondary stroke prevention; bleeding caution.

17. Clopidogrel 75 mg daily – alternative antiplatelet.

18. Atorvastatin 40 mg nightly – plaque stabilization post-stroke.

19. Losartan 50 mg daily – controls hypertension lowering recurrent stroke risk.

20. Metformin 500 mg b.i.d. – manages diabetes, indirectly preserving microvascular supply.

---

Dietary Molecular Supplements

1. Docosahexaenoic acid (DHA) 1000 mg/day – integrates into neuronal membranes, boosting plasticity.

2. Phosphatidyl-serine 200 mg/day – enhances synaptic signalling; supports memory.

3. Curcumin 500 mg with pepperine – antioxidant; dampens post-ischaemic inflammation.

4. Resveratrol 150 mg/day – activates sirtuins, possibly slowing neurodegeneration.

5. Vitamin B-complex (B1, B6, B12) – co-enzymes for neurotransmitter synthesis.

6. Magnesium L-threonate 144 mg elemental – crosses blood–brain barrier, improves synaptic density.

7. N-acetyl-cysteine 600 mg b.i.d. – glutathione precursor combating oxidative stress.

8. Co-enzyme Q10 200 mg/day – mitochondrial support.

9. Ginkgo biloba extract 120 mg/day – microvascular vasodilator; mixed evidence.

10. L-theanine 200 mg evening – promotes calm alertness aiding rehab focus.

(Always discuss supplements with a physician to avoid drug-nutrient clashes.)

---

Regenerative or Structural Drugs (Bisphosphonates, Viscosupplements, Stem-Cell Adjuncts)

Although designed for bone or joint disease, these agents sometimes feature in comprehensive neurorehabilitation plans to counter immobility-related complications or experimental neuro-restoration:

1. Alendronate 70 mg weekly (bisphosphonate) – prevents disuse osteoporosis; inhibits osteoclasts.

2. Risedronate 35 mg weekly – similar, with gentler GI profile.

3. Zoledronic acid 5 mg IV yearly – potent skeletal protection post-spinal fracture.

4. Teriparatide 20 µg sc daily – anabolic bone builder; short 24-month course.

5. Hyaluronic-acid ocular drops – viscosupplement smoothing dry eye in low-blink AVA patients.

6. Intra-articular PRP for shoulder pain; platelet growth factors maintain therapy tolerance.

7. Intranasal insulin 40 IU bid (research) – insulin-like growth factor boosts synaptogenesis in visual cortex.

8. Umbilical cord MSC infusion (trial) – stem cells secrete trophic factors; experimental, hospital-based.

9. Granulocyte-colony-stimulating factor 5 µg/kg (research) – mobilises endogenous stem cells.

10. Erythropoietin 33 000 IU IV weekly (trial) – neurotrophic effects beyond red cells.

---

Surgical or Interventional Procedures

1. Urgent decompressive craniectomy after massive occipital stroke—saves association cortex from herniation.

2. Endovascular thrombectomy within six hours restores perfusion, limiting AVA extent.

3. Carotid endarterectomy or stenting—prevents recurrent emboli hitting the ventral stream.

4. Aneurysm clipping/coiling avoids subarachnoid re-bleed.

5. Temporal-occipital lobectomy for intractable epilepsy causing progressive agnosia.

6. Low-profile tumour resection (e.g., meningioma) relieving mass effect.

7. Hydrocephalus shunt (VP shunt) normalises pressure safeguarding association fibres.

8. Vagus-nerve stimulation implant – adjunct for comorbid refractory seizures, may modulate cortical plasticity.

9. Deep-brain stimulation of anterior nucleus (investigational) to enhance memory circuits.

10. Optic nerve sheath fenestration in pseudotumor cerebri speeds vision-rehab synergy.

---

Prevention Strategies

1. Control blood pressure (<130/80 mmHg).

2. Keep LDL cholesterol <70 mg/dL.

3. Use helmets and seatbelts to prevent TBI.

4. Install CO detectors at home.

5. Vaccinate against shingles and HSV where applicable.

6. Manage atrial fibrillation with anticoagulation.

7. Quit smoking to bolster cerebral vessels.

8. Exercise 150 min weekly for neurovascular health.

9. Balance blood sugar in diabetes.

10. Regular neuro-check-ups after minor strokes.

---

When to See a Doctor

Seek prompt neurologic evaluation if you—or a loved one—can draw or copy an object yet cannot name it, especially after head injury, stroke symptoms (sudden vision, speech or balance changes), or if you notice progressive “clumsiness” with familiar items. Early imaging and rehabilitation start the clock on recovery potential ncbi.nlm.nih.gov.

---

Practical Do’s and Don’ts

Do:

1. Label household objects clearly.

2. Keep living spaces uncluttered.

3. Practise object naming daily with a helper.

4. Use multisensory cues—touch, sound, smell.

5. Wear contrasting colours when sorting laundry.

Don’t:
6. Don’t rush tasks that require object selection.
7. Don’t drive until you consistently identify road signs.
8. Avoid crowded supermarkets at peak times; shop online instead.
9. Don’t rely on memory alone—use smartphone photo lists.
10. Avoid self-medicating; always discuss new supplements or drugs with your physician.

---

Frequently Asked Questions (FAQ)

1. Is AVA the same as poor eyesight? No; the eyes see normally—only the meaning link is broken en.wikipedia.org.

2. Will glasses fix it? Ordinary lenses can’t restore semantic pathways; they only correct focus.

3. Can children develop AVA? Very rarely; most cases follow adult brain injury.

4. Is AVA progressive? It can stabilise after the acute event, but degenerative causes may worsen.

5. How long is rehab? Months to years; neuroplasticity is slow but real.

6. Does AVA affect reading? It may if pure-alexia fibres overlap; reading aloud can remain intact even when comprehension lags.

7. Are there cures? No single cure, but combination therapy markedly improves daily life.

8. Can technology help? Yes—apps for object recognition, smart labels, and speech readers are invaluable.

9. Is driving ever possible again? Only after formal occupational-therapy road assessment.

10. Do memory drugs really work? Evidence is mixed; they help some patients engage better in rehab.

11. What research looks promising? Repetitive TMS and intranasal insulin trials show early but encouraging results pmc.ncbi.nlm.nih.gov.

12. Is surgery common? Only to fix the underlying cause like tumour or aneurysm, not AVA itself.

13. Can stress make symptoms worse? Yes—stress narrows attention, so relaxation training is part of care.

14. Will vision eventually fail completely? Primary vision usually stays sharp; the problem remains recognising what is seen.

15. Where can I find support? Stroke foundations, brain injury alliances, and low-vision specialists host groups and resources.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: June 24, 2025.